0000920465-20-000013.txt : 20200113 0000920465-20-000013.hdr.sgml : 20200113 20200113161750 ACCESSION NUMBER: 0000920465-20-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200109 FILED AS OF DATE: 20200113 DATE AS OF CHANGE: 20200113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Johnson Craig A CENTRAL INDEX KEY: 0001370348 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 20523957 MAIL ADDRESS: STREET 1: C/O PURE BIOSCIENCE STREET 2: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_157895025331000.xml FORM 4 X0306 4 2020-01-09 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001370348 Johnson Craig A C/O LA JOLLA PHARMACEUTICAL COMPANY, 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 1 0 0 0 Stock Option (Right to Buy) 5.25 2020-01-09 4 A 0 30000 0 A 2030-01-09 Common Stock 30000.0 30000 D The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years. /s/ Ryan Murr, by power of attorney for Craig A. Johnson 2020-01-13